ArticleFuture science OA2021

Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer.

Michele Klain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.